Name | PROTAC CYP1B1 degrader-1 |
---|
Description | PROTAC CYP1B1 degrader-1 (Compound 6C), a α-naphthoflavone chimera derivative, is able to eliminate cytochrome P450 (CYP)1B1-mediated drug resistance via targeted CYP1B1 degradation, with IC50s of 95.1 and 9838.6 nM for CYP1B1 and CYP1A2, respectively. PROTAC CYP1B1 degrader-1 can be used for the research of CYP1B1-overexpressing prostate cancer[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C43H39N5O10 |
---|---|
Molecular Weight | 785.80 |